Dr. Prem Soman and Dr. C. Michael Gibson Discuss: Long-Term Survival Benefits and Disease Stabilization With Acoramidis In Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.